Home › Funds › Catalio Capital Management, LP › HTFL
Catalio Capital Management, LP position in HTFL
HEARTFLOW INC · Health Care
Catalio Capital Management, LP reported holding 74,969 shares of HTFL (HEARTFLOW INC) in its Q3 2026 13F filing — a position valued at US$3.7M, representing 0.70% of its reported portfolio and ranking #37 among its reported holdings. Catalio Capital Management, LP has disclosed HTFL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's HTFL position evolved
Catalio Capital Management, LP first disclosed a stake in HTFL in Q4 2025 at 113,857 shares (US$3.3M). The position peaked in Q2 2026 at 583,055 shares, worth US$17.1M. Across 4 filings, Catalio Capital Management, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 74,969 shares valued at US$3.7M — a reduction of -508,086 shares quarter over quarter.. Notable position changes include a 254% increase in Q1 2026 (shares rose 21% over the following quarter), a 44% increase in Q2 2026 (shares rose 70% over the following quarter), a 87% trim in Q3 2026 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 113.86K | $3.32M | New |
| Q1 2026 | 403.59K | $9.82M | Add |
| Q2 2026 | 583.05K | $17.11M | Add |
| Q3 2026 | 74.97K | $3.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HTFL and 13F data
HTFL (HEARTFLOW INC) is a Health Care company. 97 other funds we track also report a position in HTFL — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$221.3M), BAMCO INC /NY/ (US$124.9M), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$72.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HTFL
- Bain Capital Life Sciences Investors, LLC 4.45M sh · $221.30M · Q3 2026
- BAMCO INC /NY/ 2.51M sh · $124.87M · Q3 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 1.45M sh · $72.17M · Q3 2026
- NZS Capital, LLC 677.36K sh · $33.70M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 590.75K sh · $29.39M · Q3 2026
- Rock Springs Capital Management LP 575.00K sh · $28.61M · Q3 2026
- 12 West Capital Management LP 549.75K sh · $27.35M · Q3 2026
- Lisanti Capital Growth, LLC 155.29K sh · $7.73M · Q3 2026
- OCCUDO QUANTITATIVE STRATEGIES LP 116.44K sh · $5.79M · Q3 2026
- INTREPID FAMILY OFFICE LLC 110.00K sh · $5.47M · Q3 2026
- BROWN CAPITAL MANAGEMENT LLC 101.19K sh · $5.03M · Q3 2026
- BCWM, LLC 89.96K sh · $4.48M · Q3 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held HTFL?
Catalio Capital Management, LP has disclosed HTFL holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Catalio Capital Management, LP's current position in HTFL?
As of Q3 2026, Catalio Capital Management, LP holds 74.97K shares of HTFL (HEARTFLOW INC), valued at $3.73M, representing 0.70% of its reported portfolio and ranking #37.
Has Catalio Capital Management, LP been buying or selling HTFL?
In the latest 13F filing (Q3 2026), Catalio Capital Management, LP reduced its position in HTFL. The position peaked in Q2 2026 at 583.05K shares.
Which other funds hold HTFL?
Other major institutional holders of HTFL include Bain Capital Life Sciences Investors, LLC, BAMCO INC /NY/, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, among 97 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.